Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: Evaluating the role of RAD52 and its interactors as novel potential molecular targets for hepatocellular carcinoma

Fig. 5

Survival curves of RAD51, XRCC6, and CFL1 in HCC. a–c Overall survival (OS) curves. Significant differences between high and low expression of RAD51, XRCC6, and CFL1 were found in OS. Higher RAD51, XRCC6, CFL1 have significantly poorer OS (*P ≤ 0.05). d–f Recurrence-free survival (RFS). Higher XRCC6 or CFL1 was not associated with shorter RFS (P > 0.05). However, higher RAD51 levels have significantly poorer RFS (*P ≤ 0.05)

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us